• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ciprofloxacin in the treatment of urinary tract infections caused by Pseudomonas aeruginosa and multiresistant bacteria.

作者信息

Saavedra S, Ramírez-Ronda C H, Nevárez M

出版信息

Eur J Clin Microbiol. 1986 Apr;5(2):255-7. doi: 10.1007/BF02014004.

DOI:10.1007/BF02014004
PMID:2941296
Abstract
摘要

相似文献

1
Ciprofloxacin in the treatment of urinary tract infections caused by Pseudomonas aeruginosa and multiresistant bacteria.
Eur J Clin Microbiol. 1986 Apr;5(2):255-7. doi: 10.1007/BF02014004.
2
Ciprofloxacin in the treatment of infections caused by gentamicin-resistant gram-negative bacteria.环丙沙星治疗由耐庆大霉素革兰氏阴性菌引起的感染。
Eur J Clin Microbiol. 1986 Apr;5(2):248-51. doi: 10.1007/BF02014001.
3
Oral ciprofloxacin in resistant urinary tract infections.
Am J Med. 1987 Apr 27;82(4A):303-6.
4
[Synergism of trimethoprim and sulfamethoxazole action on microorganisms isolated from persons with urinary tract infections].[甲氧苄啶与磺胺甲恶唑对从尿路感染患者分离出的微生物的协同作用]
Med Dosw Mikrobiol. 1972;24(4):307-14.
5
Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.复方新诺明（甲氧苄啶-磺胺甲恶唑）：抗菌活性及临床疗效的最新综述
Drugs. 1982 Dec;24(6):459-518. doi: 10.2165/00003495-198224060-00002.
6
New 4-quinolones in the treatment of urinary tract infections.
Pharm Weekbl Sci. 1986 Feb 21;8(1):46-52. doi: 10.1007/BF01975480.
7
Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.在使用甲氧苄啶-磺胺甲恶唑治疗尿路感染两年后敏感性模式的改变。
Chemotherapy. 1974;20(2):97-101. doi: 10.1159/000221797.
8
New applications of old antimicrobials.老抗菌药物的新应用。
Pediatr Ann. 1986 Jun;15(6):434-5, 438-40. doi: 10.3928/0090-4481-19860601-05.
9
Evaluation of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections.环丙沙星治疗铜绿假单胞菌感染的评估。
Eur J Clin Microbiol. 1986 Apr;5(2):232-5. doi: 10.1007/BF02013996.
10
[Antibacterial action of septrin in vitro against microorganisms causing urinary tract infections in comparison with their sensitivity to other chemotherapeutic and antibiotic drugs].[与其他化疗药物和抗生素相比，复方新诺明对引起尿路感染的微生物的体外抗菌作用]
Przegl Lek. 1973;30(3):303-7.

引用本文的文献

1
Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections.口服环丙沙星治疗严重尿路感染的疗效与安全性。
Antimicrob Agents Chemother. 1987 Feb;31(2):148-50. doi: 10.1128/AAC.31.2.148.
2
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.环丙沙星：抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1988 Apr;35(4):373-447. doi: 10.2165/00003495-198835040-00003.
3
Worldwide clinical data on efficacy and safety of ciprofloxacin.

本文引用的文献

1
In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives.环丙沙星与其他新型含氟哌嗪基取代喹啉衍生物的体外活性比较。
Antimicrob Agents Chemother. 1984 Apr;25(4):518-21. doi: 10.1128/AAC.25.4.518.
2
In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.新型羧基喹啉抗菌剂环丙沙星的体外活性
Antimicrob Agents Chemother. 1984 Mar;25(3):331-5. doi: 10.1128/AAC.25.3.331.
3
Pharmacokinetics and tissue penetration of ciprofloxacin.环丙沙星的药代动力学及组织穿透性
Infection. 1988;16 Suppl 1:S29-43. doi: 10.1007/BF01650504.
4
Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis.氟喹诺酮类药物治疗泌尿生殖道感染：体外活性、药代动力学及在尿路感染和前列腺炎中的临床疗效
Antimicrob Agents Chemother. 1989 Oct;33(10):1655-61. doi: 10.1128/AAC.33.10.1655.
5
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
6
Comparison of three dosage regimens of ciprofloxacin in urinary tract infections.
Int Urol Nephrol. 1990;22(3):201-7. doi: 10.1007/BF02550393.
Antimicrob Agents Chemother. 1983 Nov;24(5):784-6. doi: 10.1128/AAC.24.5.784.
4
Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.环丙沙星、诺氟沙星、恶喹酸、西诺沙星和萘啶酸的抗菌活性。
Antimicrob Agents Chemother. 1984 May;25(5):633-7. doi: 10.1128/AAC.25.5.633.
5
In vitro activity of ciprofloxacin (Bay o 9867).环丙沙星（拜耳o 9867）的体外活性。
Antimicrob Agents Chemother. 1983 Oct;24(4):568-74. doi: 10.1128/AAC.24.4.568.
6
Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.环丙沙星（拜奥9867）、诺氟沙星、吡哌酸和萘啶酸的比较活性。
Antimicrob Agents Chemother. 1983 Aug;24(2):302-4. doi: 10.1128/AAC.24.2.302.
7
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.新型喹啉衍生物Bay 09867与其他抗菌药物的体外活性比较。
Antimicrob Agents Chemother. 1983 Apr;23(4):559-64. doi: 10.1128/AAC.23.4.559.
8
In vitro antimicrobial activity of cinoxacin against 2,968 clinical bacterial isolates.西诺沙星对2968株临床分离细菌的体外抗菌活性。
Antimicrob Agents Chemother. 1976 Jul;10(1):146-9. doi: 10.1128/AAC.10.1.146.